2019 SciTech Lecture Series: A View of the Clinical Trials Enterprise in the Twenty First Century
Name:
2019 SciTech Lecture Series: A View of the Clinical Trials Enterprise in the Twenty First Century
Date:
February 21, 2019
Time:
4:00 PM - 6:00 PM EST
Event Description:
A View of the Clinical Trials Enterprise in the Twenty First Century presented by Jennifer Byrne CEO and Board Chair, Javara
Ms. Byrne is CEO and board chair of Javara, an Integrated Research Organization (IRO) that offers comprehensive clinical research services to better align population health initiatives across value-oriented health care systems. Her involvement in the clinical research enterprise includes collaborations with hundreds of pharma, device, Contract Research Organizations (CROs), technology, site organizations, and other research service providers. Ms. Byrne currently serves as board chair for Greater Gift, a member of the Board of Trustees for The Association of Clinical Research Professionals (ACRP), and board member for The Hospice Foundation and Summit School. Additionally, she is an advisory board member to CISCRP, Wake Forest Institute of Regenerative Medicine, The Dioko Fund, and The North Carolina Biotech of the Piedmont Triad. Ms. Byrne is a graduate of Texas A&M University.
Ms. Byrne is CEO and board chair of Javara, an Integrated Research Organization (IRO) that offers comprehensive clinical research services to better align population health initiatives across value-oriented health care systems. Her involvement in the clinical research enterprise includes collaborations with hundreds of pharma, device, Contract Research Organizations (CROs), technology, site organizations, and other research service providers. Ms. Byrne currently serves as board chair for Greater Gift, a member of the Board of Trustees for The Association of Clinical Research Professionals (ACRP), and board member for The Hospice Foundation and Summit School. Additionally, she is an advisory board member to CISCRP, Wake Forest Institute of Regenerative Medicine, The Dioko Fund, and The North Carolina Biotech of the Piedmont Triad. Ms. Byrne is a graduate of Texas A&M University.
